Stock Taper
SCREENER COMPARE ANY 2 STOCKS
DRTS
ALPHA TAU MEDICAL LTD
NASDAQ
$15.03
▲ UP 2.80% (0.41)

KEY STATISTICS

Market Cap$1.36 B
52w High$15.17
52w Low$3.43
Dividend Yield—
Frequency—
P/E-14.45
Volume749.18K
Shares Out.90.33M

COMPANY

LEADERSHIP

Uzi Sofer
CHIEF EXECUTIVE
Uzi Sofer

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 8, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
121

PRICE TARGET

Target High$30.00
Target Low$8.00
Target Median$16.00
Target Consensus$18.00

UPCOMING EARNINGS

DateNov 19, 2026
DayThursday
Rev. Est.$368.25K
NOV
19
THU

PRICE

$15.03 ▲ UP 2.80% (+$0.41)
$14.60$14.80$15.00$15.209:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM15.03

About Alpha Tau Medical Ltd

https://www.alphatau.com ↗

Alpha Tau Medical Ltd. is a clinical-stage oncology company developing Alpha DaRT, a radiation therapy for solid cancers, with trials for skin, oral, pancreatic, breast, and other cancers, based in Jerusalem, Israel.

INDUSTRY

Biotechnology

A PRODUCT ALPHA TAU MEDICAL LTD IS KNOWN FOR

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy)
Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy)

Alpha DaRT is a radiation therapy using radium-224 sources to deliver targeted alpha particles for treating solid tumors, currently in clinical trials for cancers like skin, oral, pancreatic, and prostate.

COMPETITORS

COMPETITOR
ARAY COMPARE
CLRB COMPARE
LNTH COMPARE
RADX COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
15
LISTED HERE
6
RANKED BY POSITION SIZE
IEFA
0.00% · 464.4K
IZRL
1.94% · 184.4K
VALT
0.13% · 35.6K
EH
EHLS
0.62% · 25.0K
AVSD
0.03% · 7.1K
GTPE
0.01% · 168

INSTITUTIONAL OWNERSHIP

SHARES OWNED
3.29%
HOLDERS
59
TOP 12 OF 59 · RANKED BY POSITION SIZE
Hightower Advisors, LLC
875.0K sh · $6.19M
Apella Capital, LLC
382.3K sh · $3.07M
Ark Investment Management LLC
292.1K sh · $2.07M
Ubs Group AG
286.7K sh · $2.03M
Hoylecohen, LLC
269.1K sh · $680.79K
Levin Capital Strategies, L.P.
204.7K sh · $923.26K
Kovitz Investment Group Partners, LLC
203.2K sh · $916.57K
Mariner, LLC
146.4K sh · $1.04M
Millennium Management LLC
107.8K sh · $533.68K
Jane Street Group, LLC
75.5K sh · $534.06K
Etf Managers Group, LLC
66.3K sh · $190.36K
Renaissance Technologies LLC
61.9K sh · $279.17K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
Levy Raphi
Purchase · 2.9K shares
2026-08-21
★
OFFICER: CHIEF FINANCIAL OFFICER
Levy Raphi
Purchase · 17.7K shares
2026-08-11
★
OFFICER: CHIEF FINANCIAL OFFICER
Levy Raphi
Purchase · 2.3K shares
2026-07-06
★
OFFICER: CHIEF FINANCIAL OFFICER
Levy Raphi
Purchase · 17.9K shares
2026-07-02

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
OVERWEIGHT 1
NEUTRAL 1
5 GRADES IN THE LAST 12 MONTHS
Barclays OVERWEIGHT HC Wainwright & Co. BUY Piper Sandler NEUTRAL Ladenburg Thalmann BUY Citigroup BUY

SECTORS PEERS

PEERPRICE
ANRO$35.80COMPARE
CADL$12.97COMPARE
LRMR$3.85COMPARE
DMAC$6.79COMPARE
DBVT$13.56COMPARE
CLLS$3.22COMPARE
ACIU$2.85COMPARE
AMRN$13.62COMPARE